Extrawell Pharma announces shareholder meeting

• Extrawell Pharmaceutical will hold its annual general meeting in Causeway Bay, Hong Kong on Aug. 28, 2026.
• Shareholders will vote on general mandates to issue up to 580,000,000 new shares, based on 2,900,000,000 shares outstanding.
• A buyback mandate covering up to 290,000,000 shares is also up for approval, with an extension mandate to expand the issuance limit by repurchased shares.
• Director elections include Guo Yi standing for re-election, Yang Xiaorong standing for re-election, with Lou Yi set to retire.
• The meeting will also vote on reappointing ZSZH (HK) Fuson CPA as auditor, with an estimated audit fee of HK$850,000 to HK$900,000.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Extrawell Pharmaceutical Holdings Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260730-12261492), on July 30, 2026, and is solely responsible for the information contained therein.